FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.400
-0.035 (-8.00%)
At close: Mar 9, 2026, 4:00 PM EDT
0.425
+0.025 (6.30%)
After-hours: Mar 9, 2026, 7:59 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $27.05 million as of March 9, 2026. Its market cap has decreased by -41.26% in one year.
Market Cap
27.05M
Enterprise Value
24.64M
1-Year Change
-41.26%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $27.05M, a decrease of -97.14%. That is a compound annual growth rate of -81.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 29.40M | 96.55% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 31.54M |
| Tempest Therapeutics | 31.14M |
| Werewolf Therapeutics | 30.67M |
| Lantern Pharma | 30.20M |
| Tevogen Bio Holdings | 29.59M |
| RenovoRx | 28.96M |
| NeuroSense Therapeutics | 28.92M |
| Dyadic International | 27.78M |